|
LSM11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.396800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.639060E-04 |
| Normal-vs-Stage2 |
3.529400E-01 |
| Normal-vs-Stage3 |
4.487000E-01 |
| Normal-vs-Stage4 |
9.162800E-01 |
| Stage1-vs-Stage2 |
1.374020E-01 |
| Stage1-vs-Stage3 |
2.495800E-03 |
| Stage1-vs-Stage4 |
2.977600E-04 |
| Stage2-vs-Stage3 |
6.643600E-01 |
| Stage2-vs-Stage4 |
3.927400E-01 |
| Stage3-vs-Stage4 |
5.325400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.216000E-03 |
| Normal-vs-AfricanAmerican |
7.690200E-01 |
| Normal-vs-Asian |
1.315170E-03 |
| Caucasian-vs-AfricanAmerican |
1.706840E-01 |
| Caucasian-vs-Asian |
8.956400E-02 |
| AfricanAmerican-vs-Asian |
4.624100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.029900E-02 |
| Normal-vs-Female |
1.740110E-02 |
| Male-vs-Female |
6.495200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.784000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.419200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.094980E-01 |
| Normal-vs-Age(81-100Yrs) |
9.307800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.804600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.828800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.310200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.763500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.032000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.946200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.528300E-02 |
| Normal-vs-Grade 2 |
3.94719999999849E-05 |
| Normal-vs-Grade 3 |
2.488800E-01 |
| Normal-vs-Grade 4 |
5.119200E-01 |
| Grade 1-vs-Grade 2 |
4.701200E-01 |
| Grade 1-vs-Grade 3 |
3.100100E-02 |
| Grade 1-vs-Grade 4 |
3.177100E-03 |
| Grade 2-vs-Grade 3 |
6.199800E-04 |
| Grade 2-vs-Grade 4 |
1.55380999999899E-05 |
| Grade 3-vs-Grade 4 |
9.866400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.08539999999991E-05 |
| Normal-vs-ccB subtype |
1.125420E-01 |
| ccA subtype-vs-ccB subtype |
1.375660E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.860120E-02 |
| Normal-vs-N1 |
5.085800E-01 |
| N0-vs-N1 |
6.641000E-01 |
|
|
